In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Moderated Posters Awards

Presenters from abstracts selected for a presentation in a Moderated Posters session during ESC Congress are in competition for the best Moderated Poster.

Moderated Posters Awards 2019

Congratulations to the winners of the Moderated Posters Awards Sessions 2019!

Winners by topics

Winners by sessions

Tuesday 03 September
Monday 02 September
Sunday 01 September


Saturday 31 August


Moderated Posters Awards 2018

Congratulations to the winners of the Moderated Posters Awards Sessions 2018!

Overall winners by topics

Winners by sessions

Tuesday 28 August
Monday 27 August
Sunday 26 August
Saturday 25 August

Moderated Posters Awards 2017

Congratulations to the winners of the Moderated Posters Awards Sessions 2017!

Overall winners by topics

Winners by sessions

Tuesday 29 August PM
Tuesday 29 August AM
Monday 28 August PM
Monday 28 August AM
Sunday 27 August PM
Sunday 27 August AM
Saturday 26 August

Moderated Posters Awards 2016

Congratulations to the winners of the Moderated Posters Awards Sessions 2016!

Overall winners by topics

Winners by sessions

Tuesday 30 August - 15:00
Tuesday 30 August - 10:00
Monday 29 August - 15:30
Monday 29 August - 10:00
Sunday 28 August - 15:30
Sunday 28 August - 10:00
Saturday 27 August - 12:30

Moderated Posters Awards 2015

Congratulations to the winners of the Moderated Posters Awards Sessions 2015!

Overall Winners by topics

Winners by sessions

Tuesday 1 September - 15:30
      • Marc Jolicoeur, Canada
        Management in heart failure: new perspectives:  Influence of angina and revascularization in patients with left ventricular systolic dysfunction and coronary artery disease: insights from the STICH trial.
      • Lars Wallentin, Sweden
        What's next in cardiovascular risk prediction? Biomarker-based risk score for prediction of cardiovascular events in stable coronary heart disease - Experiences from the STABILITY biomarker substudy.
      • Nico Hartmann, Germany
        Outcomes after TAVI: Seven-year outcome after TAVI
      • Oana Mirea, Belgium
        New techniques and new applications in echocardiography:  Effect of afterload increase on left ventricle mechanical dispersion and electromechanical window.
      • Jeroen Venlet, Netherlands
        Ventricular arrhythmias: stratification and treatment: Critical progressive activation delay after premature stimulation is associated with polymorphic ventricular tachycardia in nonischemic cardiomyopathy: results from the Leiden NICM Study.
      • Stephane Fournier, Switzerland
        Reperfusion of STEMI: Circadian variation of intracoronary thrombus aspiration efficacy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
      • Josebe Goirigolzarri Artaza, Spain
        New techniques and new applications in echocardiography:  Validation of 2D strain parameters in the diagnosis of acute rejection after heart trasplantation.
      • Junjing Su, Denmark
        Differentiating pulmonary arterial hypertension from other pulmonary hypertension groups: Impact of atrial contraction on diagnosis of pre- versus post-capillary pulmonary hypertension.
      • Jerrold Levy, United States of America
        Anti-thrombotics in clinical practice:  Initial experience with idarucizumab in dabigatran-treated patients requiring emergency surgery or interventon: interim results from the RE-VERSE AD study.
      • Shizuya Yamashita, Japan
        Treatment of hypercholesterolemia. A vision to the future: Effect of K-877, a potent and selective PPAR alpha modulator (SPPARM alpha), on cholesterol efflux from macrophages in dyslipidemic patients.
Tuesday 1 September - 10:00
      • Elizabeth Feijen, Netherlands
        Ominous signs in heart failure: Time-related cumulative incidence of congestive heart failure after childhood cancer treatment; a DCOG LATER study.
      • Mahir Karakas, Germany
        Advancing the clinical application of biomarkers: Prognostic value of circulating MicroRNAs in patients with coronary artery disease - results from the AtheroGene study.
      • Yoshihisa Yamada, Japan
        Cardiovascular dysfunction and repair - Roles of inflammation and immune cells: Sphigosine-mono-phosphate (S1P) induces the migration of Muse cells but not non-Muse cells toward the rabbit post-infarct heart and contributes to the improvement of cardiac function and remodeling.
      • Juliana Reis Pires Martins, Portugal
        Acute phase of STEMI:  Revascularization strategies in patients with ST-segment elevation myocardial infarction and multivessel disease in a real world population.
      • S Benedict Freedman, Australia
        Antithrombotic prophylaxis in atrial fibrillation: High burden of potentially avoidable stroke from discontinuation of warfarin therapy in non-valvular atrial fibrillation.
      • Alexios Antonopoulos, Greece
        Advances in cardiac computed tomography imaging:  Epicardial adipose tissue expansion and differentiation status predict myocardial redox state and coronary calcification.
      • Benjamin Alos, France
        Outcomes after TAVI: Seven-year outcome after TAVI
      • Tatsunori Takahashi, Japan
        Understanding pathophysiology from imaging and functional assessment: Usefulness of optical coherence tomography in determining the mechanisms of myocardial infarction in patients without angiographically demonstrable coronary artery disease.
      • Hisaki Makimoto, Japan
        Hypertension and comorbidities: a challenge of treatment:  Diverge responses of cardiac autonomic function to beta-blocker therapy depending on chronic kidney disease.


Monday 31 August - 15:30
      • Sanne De Jong, Netherlands
        Heart failure: diversity of phenotyping:  MicroRNAs as a quantitative and prognostic biomarker of interstitial cardiac fibrosis in pressure overloaded mice.
      • Adam Kenneth McDiarmid, United Kingdom
        Differentiating physiological adaptation from cardiac pathology in athletes: Athletic cardiac adaptation is secondary to increased myocyte mass.
      • Javier Barallobre-Barreiro, United Kingdom
        Extracellular matrix, remodelling and inflammation: Glycoproteomics analysis of cardiac extracellular matrix reveals the presence of decorin fragments with anti-myostatin and anti-fibrotic activity.
      • Steen Hansen, Denmark
        Pre-hospital phase of STEMI: Increased dissemination of registered AEDs is associated with higher rate of bystander defibrillation in public locations but not in residential areas - a nationwide study.
      • Elmir Omerovic, Sweden
        Atrial fibrillation in real world: Atrial fibrillation in patients admitted to coronary care units in western Sweden. focus on obesity and lipotoxicity
      • Axel Bauer, Germany
        Information technology applications in cardiology: Assessment of deceleration capacity from short-term recordings  predicts mortality after myocardial infarction.
      • Oliver Husser, Germany
        Aortic stenosis - From basics to prognosis: Combining tumor marker carbohydrate antigen 125 and the logistic EuroSCORE improves risk stratification in patients undergoing transcatheter aortic valve implantation.
      • Sergio Leonardi, Italy
        Prediction models in clinical practice: Implications of different criteria for percutaneous coronary intervention-related myocardial infarction on study results of three large phase III clinical trials: the CHAMPION experience.
      • Yan Zhang, China, People's Republic of
        Hypertension pathophysiology II: Non-invasive central systolic blood pressure not peripheral systolic blood pressure associated with kidney function decline in a chinese community-based population.
Monday 31 August - 10:00
      • Xavier Jouven, France
        Hypertension treatment: Quality of cardiovascular drugs in street markets and pharmacies in 10 sub-saharan
      • Timm Bauer, Germany
        Management of procedural risks: Disaster in the cath lab - cardiogenic shock induced by procedure: results from the EHS PCI registry.
      • Louise Eske Bruun, Denmark
        Advances in endocarditis: Socioeconomic status and risk of staphylococcus aureus bacteremia - a danish nationwide cohort study .
      • Satish Chacko, United States of America
        Cardiovascular magnetic resonance - Ischaemic heart disease: Prognostic significance of global myocardial perfusion reserve measured using coronary sinus flow during stress cardiovascular magnetic resonance imaging.
      • Abdul Shokor Parwani, Germany
        Different aspects in management of atrial fibrillation: Relationship between reduced left atrial function and electro-anatomical remodeling in patients undergoing atrial fibrillation ablation.
      • Tomasz Mazurek, Poland
        Experimental and clinical research in myocardial ischaemia:  Inflammatory activity of pericoronary adipose tissue in prediabetic patients with NSTE-ACS.
      • Christian Kupatt, Germany
        New advances in cardiovascular genetics and gene therapy: Impact of diabetes mellitus on Thymosin B4 mediated therapeutic neovascularization.
      • Adrian Cid Menendez, Spain
        Impact of smoking cessation on cardiovascular prognosis: myths and reality: Prognostic influence of smoking in patients with an acute myocardial infarction: paradox or confusion? a propensity-score matched analysis.
      • Camilla Hage, Sweden
        Diastolic dysfunction: Inflammatory biomarkers predict HF severity and prognosis in patients with heart failure with preserved ejection fraction. african countries: the seven study.


Sunday 30 August - 15:30
      • Joerg Eiringhaus, Germany
        Basic mechanisms in heart failure: Ca-homeostasis in human cardiac hypertrophy and end stage heart failure is directly impacted by modulations of protein phosphatase 1 and -2a activity.
      • Guy De Backer, Belgium
        What does epidemiology teach us about cardiovascular risk? Prevalence and management of familial hypercholesterolaemia in the euroaspire iv project.
      • Alessandra Frigiola, United Kingdom
        Challenges in repaired tetralogy of Fallot: Relation between exercise capacity and skeletal muscle metabolism during exercise in patients with repaired tetralogy of Fallot.
      • Colin Stirrat, United Kingdom
        Cardiovascular magnetic resonance - Translational: Ultrasmall superparamagnetic particles of iron oxide-enhanced magnetic resonance imaging in the assessment of cellular inflammation after myocardial infarction.
      • Giuseppe Boriani, Italy
        Antibradycardia pacing: Time course of detection of new atrial fibrillation (AF) and AF burden in patients with cardiac implanted electronic devices.
      • Federica Ilardi, Italy
        Improving antiplatelets regimen and cardioprotection in coronary patients: Rac-1 as a new target to modulate endothelial function and platelet aggregation in diabetes mellitus.
      • Gemma Vilahur Garcia, Spain
        Diet, lipids and the vasculature: Dyslipidemia impairs high-density lipoprotein cardioprotective effects leading to larger infarcts. HDL-characterization by lipid analysis and differential proteomics.
      • Jouke Bokma, Netherlands
        Challenges in repaired tetralogy of Fallot: QRS fragmentation is superior to QRS duration in the prediction of death or ventricular tachycardia in adults with tetralogy of Fallot.
      • Claudio Muneretto, Italy
        Current status and future directions of coronary artery bypass grafting: Long term follow-up following total arterial versus conventional and hybrid myocardial revascularisation: a propensity-match analysis.
      • Moo Young Rhee, Korea, Republic of
        Hypertension and haemodynamics: Aorta-to-upper arm pulse wave transit time ratio can predict the risk of coronary artery disease and stroke better than pulse wave velocity.
Sunday 30 August - 10:00
      • Konstantinos Toutouzas, Greece
        Myocardial function: The impact of left ventricular function and balloon aortic valvuloplasty on paravalvular leakage in patients undergoing TAVI.
      • Robert Patrick Giugliano, United States of America
        Managing lipids - Statins and beyond: Prospectivev evaluation of cancer in 18,144 patients randomized to ezetimibe vs placebo: a prespecified analysis from the IMPROVE IT trial.
      • Sander Trenson, Belgium
        Clinical impact and modulation of endothelial (dys)function: Altered molecular signature of cardiac microvascular endothelium after chronic pressure overload and transition to heart failure.
      • Debbie Kalkman, Netherlands
        Knowing more about STEMI and non-STEMI: Comparison of 10-Year follow-up mortality rates in a randomized trial comparing routine invasive versus selective invasive management in patients with non ST-segment elevation acute coronary syndrome.
      • Anna Polewczyk, Poland
        Complications in devices: Analysis of efficacy and safety of transvenous leads extraction and long term mortality after procedures in women and men.
      • Michael Huntgeburth, Germany
        What's new in imaging for valvular heart disease? Novel method for determination of mitral regurgitation severity before and after percutaneous edge-to-edge mitral valve repair by contrast echocardiography.
      • Milind Desai, United States of America
        Advances in cardiomyopathies: Outcomes of hypertrophic cardiomyopathy patients undergoing non-cardiac surgery: A cohort study with matched non hypertrophic cardiomyopathy patients.
      • Yusuke Tomoi, Japan
        Assessing percutaneous treatment options for PAD: Optimal revascularization strategy for in-stent occlusion after femoro-popliteal stenting.
      • Lorenzo DiCarlo, United Kingdom
        Hypertension: devices and interventions: Transforming the information highway for the clinical management of blood pressure using an ambulatory setting, objective assessment, and digital communication.
Saturday 29 August - 12:30
      • Akshay Suvas Desai, United States of America
        Heart failure therapy: Factors associated with dropout during the run-in period prior to randomization in PARADIGM-HF.
      • Nobutaka Ikeda, Japan
        From pre-diabetes to vascular complications: Impact of serum 1,5-anhydro-d-glucitol level on prediction of major adverse cardiac and cerebrovascular events.
      • Bram Trachet, Switzerland
        News in cardiac anatomy: Branch-related ruptures cause intramural hematoma and dissecting abdominal aortic aneurysm in angiotensin II-infused ApoE -/- mice.
      • Ronak Delewi, Netherlands
        Post myocardial infarction outcome: Long term myocardial recovery after revascularization for ST-segment elevation myocardial infarction as assessed by cardiac magnetic resonance imaging.
      • Damien Voilliot, France
        Updates on ICD therapy: Primary prevention indication for implantable cardioverter-defibrillator  in post infarct patients: the value of myocardial infarction scar characterization by magnetic resonance imaging.
      • Mischa Rijnierse, Netherlands
        Developments in nuclear cardiology, prognosis, risk stratification and management strategies: Effect of beta-blocking therapy on cardiac sympathetic nerve function in patients with idiopathic pulmonary arterial hypertension.
      • Antonio Brucato, Italy
        Prognosis in pericardial disease: Recurrent pericarditis in children and adolescents.A multicentre cohort study.
      • Yae Matsuo, Japan
        Percutaneous non-coronary techniques for stroke prevention: Long term result of the left atrial appendage closure for stroke prevention in single high volume center.
      • Jan Vaclavik, Czech Republic
        Hypertension pathophysiology I: Hypertension control and medication burden in patients with additional risk factors in central and eastern europe.

Moderated Posters Awards 2014

      • Bromage Dan
      • Porta Sanchez Andreu
      • Segreti Luca
      • Lourenco Patricia
      • Menezes Alves Da Costa Leandro
      • La Gerche Andre
      • Perazzolo Marra Martina
      • Moderated Posters Awards 2013
      • Kazuhiro Matsuo, Japan
      • Baris Gencer, Switzerland
      • Karolina Szummer, Sweden
      • Ling Li Teo, Singapore
      • Taisuke Ishikawa, Japan
      • Ralph Stephan Von Bardeleben, Germany
      • Tim Van de Hoef, Netherlands
      • Grzegorz Bilo, Italy
      • Murray Matangi, Canada
      • Spescha Remo
      • Khalid Usman
      • Paikin Jeremy
      • Leening Maarten
      • Igland Jannicke
      • Alraies Chadi
      • Verloop Willemien
      • Ujiie Yuichi

Moderated Posters Awards 2012

      • Marrian
      • Takashi Yamada
      • Pierpaolo Pellicori
      • Ismo Anttila
      • Antonios Antoniadis
      • Constantinos O'Mahony
      • Sebastian Szardien
      • Sebastiaan Piers
      • Alexander Lauten
      • Juergen Leick
      • Jef Geens
      • David Erlinge
      • Bruna Gigante
      • Peter Kolkhof
      • Gyongyosi

Moderated Posters Awards 2011

      • Mary N Sheppard
      • Massimiliano Palazzini
      • Kim Lamont
      • Gaetano Maria De Ferrari
      • Gaetano Nucifora
      • Yuan-Hung Liu
      • Christian Ukena
      • Liza Thomas
      • Lelane Van Der Poel
      • Toshinari Onishi
      • Guillaume Jondeau
      • Carsten Skurk
      • Erik Tandberg Askevold

Moderated Posters Awards 2010

      • Philipp Stieger
      • Yoshiji Yamada
      • Anselm Kai Gitt
      • Giovanna Liuzzo
      • Daphne Babalis
      • Milos Taborsky
      • Alberto Bouzas Mosquera
      • Felix Woitek
      • Aaron Kee Fui Wong
      • Nikolaos Bonaros
      • Navin Chandra
      • Caroline Veltman
      • Massimo Lacoviello
      • Carolyn Sp Lam

Moderated Posters Awards 2009

      • Yvette Van Gestel
      • Matteo Cameli
      • Javier Lopez-Diaz
      • Bimmer Claessen
      • Jun Ni
      • Mario Previtali
      • Robert Fisher
      • Susanne Brenner
      • Enrique Santas
      • Christian Templin
      • Ioannis Laoutaris
      • Gianranco Parati
      • Piotr Musialek
      • Thomas Pilgrim

Moderated Posters Awards 2008

      • Anders Sahlen
      • Canan Nebigil
      • Danilo Neglia
      • Nick Clappers
      • Rene A Tio
      • Anastasios Athanasiadis
      • Yu Ting Tan
      • Paola Meregalli
      • Daniel Fernadez Berges
      • Alessandra Serio
      • Renato Lopes
      • John Eikelboom
      • David Busseuil
      • Robert Gerber
      • Robert Doughty

Moderated Posters Awards 2007

    • Alexander Staudt
    • Martyn Farrer
    • Mateusz Orzalkiewicz
    • Stephan
    • Masaya Tanno
    • Laurent Louis Andre de Kerchove
    • Birke Schneider
    • Stephan Jacobs
    • Stavros Chrysostomakis
    • Fabien Hyafil
    • Roman Arnold
    • Gielsen
    • Fausto Rigo
    • Nika Skoro-Sajer
    • Dorothea Siegel-Axel